← Back to Dashboard

Kaletra

Protease inhibitor + CYP3A4 booster

Constituent drugs (2)

Lopinavir

Loading structure...
Loading 3D structure...
PubChem CID 92727

Ritonavir

Loading structure...
Loading 3D structure...
PubChem CID 392622

Chemical Identifiers

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral protease
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (kegg.jp) Approval ref (pmda.go.jp) PMDA approved 2000/12/12fixed-dose combination of Lopinavir, Ritonavir.